OSSFF (Embla Medical hf) Cyclically Adjusted FCF per Share: $0.20 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSSFF Embla Medical hf OSSFF
91 GF Score
Price $4.15
GF Value $4.78
View Full Analysis

What is Embla Medical hf Cyclically Adjusted FCF per Share?

Embla Medical hf OSSFF 91 Cyclically Adjusted FCF per Share is $0.20 as of Jun. 2026. GuruFocus rates OSSFF with a GF Score™ of 91/100 and a GF Value™ of $4.78.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Embla Medical hf's adjusted free cash flow per share for the three months ended in Jun. 2026 was $0.072. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.20 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Embla Medical hf's average Cyclically Adjusted FCF Growth Rate was 11.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 7.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Embla Medical hf was 10.40% per year. The lowest was 5.50% per year. And the median was 7.90% per year.

As of today (2026-08-18), Embla Medical hf's current stock price is $4.15. Embla Medical hf's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $0.20. Embla Medical hf's Cyclically Adjusted Price-to-FCF of today is 20.75.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Embla Medical hf was 77.36. The lowest was 20.83. And the median was 41.25.


Embla Medical hf  (OTCPK:OSSFF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Embla Medical hf's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4.15/0.20
=20.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Embla Medical hf was 77.36. The lowest was 20.83. And the median was 41.25.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Embla Medical hf Cyclically Adjusted FCF per Share Related Terms


Embla Medical hf Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf Cyclically Adjusted FCF per Share Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.13 0.16 0.14 0.19

Embla Medical hf Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.18 0.19 0.19 0.20

OSSFF vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Embla Medical hf's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Cyclically Adjusted Price-to-FCF falls into.


OSSFF
91GF Score
Embla Medical hf OSSFF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Embla Medical hf's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.072/161.3100*161.3100
=0.072

Current CPI (Jun. 2026) = 161.3100.

Embla Medical hf Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.037 102.457 0.058
201612 0.037 102.562 0.058
201703 0.005 102.768 0.008
201706 0.031 103.496 0.048
201709 0.034 103.871 0.053
201712 0.057 104.481 0.088
201803 -0.011 105.600 -0.017
201806 0.022 106.206 0.033
201809 0.042 106.727 0.063
201812 0.036 108.388 0.054
201903 0.010 108.702 0.015
201906 0.042 109.758 0.062
201909 0.086 109.922 0.126
201912 0.015 110.588 0.022
202003 0.039 111.019 0.057
202006 0.046 112.667 0.066
202009 0.053 113.772 0.075
202012 0.026 114.542 0.037
202103 0.023 115.833 0.032
202106 0.051 117.451 0.070
202109 0.031 118.723 0.042
202112 0.066 120.398 0.088
202203 0.011 123.555 0.014
202206 0.004 127.809 0.005
202209 0.028 129.810 0.035
202212 0.037 131.901 0.045
202303 -0.005 135.674 -0.006
202306 0.025 139.150 0.029
202309 0.041 140.147 0.047
202312 0.063 142.125 0.072
202403 -0.017 144.910 -0.019
202406 0.041 147.267 0.045
202409 0.076 147.722 0.083
202412 0.082 148.871 0.089
202503 0.018 150.393 0.019
202506 0.029 153.367 0.031
202509 0.089 153.800 0.093
202512 0.101 155.560 0.105
202603 0.009 158.510 0.009
202606 0.072 161.310 0.072

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.20 mean?
Embla Medical hf (OSSFF) has a Cyclically Adjusted FCF per Share of $0.20 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Embla Medical hf and its competitors.
Is Embla Medical hf's Cyclically Adjusted FCF per Share too high?
Embla Medical hf's current Cyclically Adjusted FCF per Share is $0.20. Overall, Embla Medical hf has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Embla Medical hf's Cyclically Adjusted FCF per Share of $0.20 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current Cyclically Adjusted FCF per Share is $0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Cyclically Adjusted FCF per Share of $0.20. The stock's GF Value™ is $4.78, compared to a current price of $4.15 — trading 13.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.20. Embla Medical hf's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Cyclically Adjusted FCF per Share is $0.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (OSSFF) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of $4.15 is trading 13.2% below its estimated GF Value™ of $4.78.

Key valuation signals for OSSFF:

  • Cyclically Adjusted FCF per Share: $0.20
  • GF Value™: $4.78 vs. price of $4.15 (13.2% below fair value)
  • GF Score™: 91/100

No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Embla Medical hf Business Description

Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
91GF Score

Get the complete analysis for OSSFF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15
Price
$4.78
GF Value